The Breast Cancer Research Foundation of Alabama today announced an investment of $1.05 million in Alabama-based breast cancer research, bringing the organization’s total impact over 25 years to nearly $11 million. Matching their 2019 investment, the organization will support 14 research projects throughout the state, including studies at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB), Auburn University, Cerflux, Mitchell Cancer Institute at University of South Alabama, Tuskegee University and Southern Research.

Funding was raised in 2020 by corporate sponsorships, special events, individual donations, grants from local, state and federal funders, and sales of the Breast Cancer Research specialty license plate.

“Despite COVID-19, individuals and companies throughout the state stepped up for breast cancer research,” said Beth Bradner Davis, executive director of the BCRFA. “Our staff and board are truly thrilled to match last year’s investment, allowing us to support critical projects which will change therapies and treatments for breast cancer patients here in Alabama and around the world. Unfortunately, diagnoses don’t stop during a pandemic. This investment will ensure that research won’t either.”

Read more about this year's funding recipients and projects.


About the Breast Cancer Research Foundation of Alabama

The Breast Cancer Research Foundation of Alabama supports a comprehensive approach to battling breast cancer through support of collaborative and innovative research to help diagnose, treat, prevent and eradicate the disease. Since its inception in 1996, the BCRFA has raised almost $11 million to fund research at the O’Neal Comprehensive Cancer Center and with their collaborative partners. All funds raised stay here in the state of Alabama, but the research will have a global, life-saving impact. To learn more, visit bcrfa.org.